These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

177 related items for PubMed ID: 4152781

  • 1. Anti-lymphocytic antibodies and marrow transplantation. 3. Effect of heterologous anti-brain antibodies on acute secondary disease in mice.
    Rodt H, Thierfelder S, Eulitz M.
    Eur J Immunol; 1974 Jan; 4(1):15-9. PubMed ID: 4152781
    [No Abstract] [Full Text] [Related]

  • 2. Antilymphocytic antibodies and marrow transplantation. IV. Comparison of the effects of antibody fragments directed against immunoglobulin or lymphocyte antigens on acute secondary disease.
    Rodt H, Therfelder S, Eulitz M.
    Exp Hematol; 1974 Jan; 2(4):195-203. PubMed ID: 4156327
    [No Abstract] [Full Text] [Related]

  • 3. In vivo activity of cytotoxic lymphocytes.
    Cerottini JC, Freedman LR, Brunner KT.
    Transplant Proc; 1972 Sep; 4(3):299-301. PubMed ID: 4404149
    [No Abstract] [Full Text] [Related]

  • 4. Adaptive phenomena in bone marrow transplantation.
    Goujet-Zalc C, Ilbery PL.
    Exp Hematol; 1973 Sep; 1(1):3-10. PubMed ID: 4154047
    [No Abstract] [Full Text] [Related]

  • 5. Studies on the effect of a thymic humoral factor on differentiation of thymus-derived lymphocytes.
    Lonai P, Mogilner B, Rotter V, Trainin N.
    Eur J Immunol; 1973 Jan; 3(1):21-6. PubMed ID: 4146225
    [No Abstract] [Full Text] [Related]

  • 6. Prevention of graft-versus-host disease by Fab fragments derived from ALG.
    Richie ER, Gallagher MT, Trentin JJ.
    Transplant Proc; 1973 Mar; 5(1):873-6. PubMed ID: 4144467
    [No Abstract] [Full Text] [Related]

  • 7. Mouse bone marrow lymphocytes and their differentiation.
    Ryser JE, Vassalli P.
    J Immunol; 1974 Sep; 113(3):719-28. PubMed ID: 4213258
    [No Abstract] [Full Text] [Related]

  • 8. [Effects of a heterologous immune serum against bone marrow cells of the mouse].
    von Broen B.
    Acta Biol Med Ger; 1974 Sep; 32(6):681-90. PubMed ID: 4153702
    [No Abstract] [Full Text] [Related]

  • 9. Antilymphocytic antibodies and marrow transplantation. VII. Two of nine monoclonal anti-Thy-1 antibodies used for pretreatment of donor marrow suppressed graft-versus-host reactions without added complement.
    Thierfelder S, Cobbold S, Kummer U, Waldmann H, Schuh R.
    Exp Hematol; 1985 Oct; 13(9):948-55. PubMed ID: 2864278
    [Abstract] [Full Text] [Related]

  • 10. [Use of heterologous antireceptor antibodies for specific reversal of acute homologous disease in mice].
    Nesterenko VG, Gruner Sh, Rubakova EI, Babadzhanov AS.
    Biull Eksp Biol Med; 1980 Nov; 90(11):588-90. PubMed ID: 7192584
    [Abstract] [Full Text] [Related]

  • 11. Regulation of the immune response. X. Antigen-antibody complex inactivation of cells involved in adoptive transfer.
    Sinclair NR, Lees RK, Abrahams S, Chan PL, Fagan G, Stiller CR.
    J Immunol; 1974 Nov; 113(5):1493-500. PubMed ID: 4608468
    [No Abstract] [Full Text] [Related]

  • 12. Delayed secondary disease in mice after early or late therapy with anti-thymocyte serum.
    Kinnamon KE, Blackwell LH, Ledney GD.
    Exp Hematol; 1973 Nov; 1(4):202-14. PubMed ID: 4154088
    [No Abstract] [Full Text] [Related]

  • 13. Antilymphocytic antibodies and marrow transplantation. V. Suppression of secondary disease by host-versus-theta-graft reaction.
    Thierfelder S, Rodt H.
    Transplantation; 1977 Jan; 23(1):87-92. PubMed ID: 319574
    [Abstract] [Full Text] [Related]

  • 14. [Cytotoxic lymphocytes and anti-tumor immunity].
    Cerottini JC, Brunner KT.
    Ann Inst Pasteur (Paris); 1972 Apr; 122(4):659-68. PubMed ID: 4403239
    [No Abstract] [Full Text] [Related]

  • 15. In vivo studies of the role of cytotoxic T cells in tumor allograft immunity.
    Freedman LR, Cerottini JC, Brunner KT.
    J Immunol; 1972 Dec; 109(6):1371-8. PubMed ID: 4538966
    [No Abstract] [Full Text] [Related]

  • 16. Suppression of acute secondary disease by heterologous anti-brain serum.
    Rodt HV, Thierfelder S, Eulitz M.
    Blut; 1972 Dec; 25(6):385-9. PubMed ID: 4641722
    [No Abstract] [Full Text] [Related]

  • 17. Interaction of anti-thymocyte serum with hematopoietic stem cells. I. Effects in vitro and in vivo.
    Mookerjee BK, Azzolina L, Poultar L.
    J Immunol; 1974 Feb; 112(2):822-9. PubMed ID: 4149885
    [No Abstract] [Full Text] [Related]

  • 18. Effect of selective T cell depletion of host and/or donor bone marrow on lymphopoietic repopulation, tolerance, and graft-vs-host disease in mixed allogeneic chimeras (B10 + B10.D2----B10).
    Ildstad ST, Wren SM, Bluestone JA, Barbieri SA, Stephany D, Sachs DH.
    J Immunol; 1986 Jan; 136(1):28-33. PubMed ID: 2933464
    [Abstract] [Full Text] [Related]

  • 19. Prevention of acute graft-versus-host (GVH) mortality with spleen-absorbed antithymocyte globulin (ATG).
    Trentin JJ, Judd KP.
    Transplant Proc; 1973 Mar; 5(1):865-8. PubMed ID: 4540468
    [No Abstract] [Full Text] [Related]

  • 20. Significance of antigen binding by T cells.
    Charreire J, Bach JF.
    Transplant Proc; 1973 Dec; 5(4):1735-7. PubMed ID: 4130079
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.